ライフサイエンスコーパス: serum magnesium

1 ificantly correlated with increased level of serum magnesium.

2 ry (EA) populations identified nine loci for serum magnesium.

3 xtend our understanding of the metabolism of serum magnesium.

4 Low serum magnesium and high serum phosphorus and calcium we

5 of HF is greater among individuals with low serum magnesium and those with high serum phosphorus and

6 analysis to examine the association between serum magnesium at baseline and risk of incident AF.

7 Serum magnesium, bicarbonate, albumin, and phosphate lev

8 owed a statistically significant increase in serum magnesium concentration at 6 hrs when compared wit

9 ficant trends in fracture risk in men across serum magnesium concentration groups were apparent for s

10 together explained 2.8 % of the variance in serum magnesium concentration in ARIC African-American p

11 loci that explained 2.8% of the variance in serum magnesium concentration in ARIC African-American p

12 se and MUC1 and between insulin and TRPM6 on serum magnesium concentration in ARIC European-American

13 The change in serum magnesium concentration was greater in women consu

14 gated associations of BUA and fractures with serum magnesium concentration.

15 onic Health Evaluation II scores, or initial serum magnesium concentration.

16 Serum magnesium concentrations did not differ after 12 w

17 um potassium concentrations of 3.5 mmol/L or serum magnesium concentrations of < 1.8 mg/dL (< 0.74 mm

18 ine magnesium concentrations, the changes in serum magnesium concentrations were not significantly di

19 Low serum magnesium has been linked to increased risk of atr

20 The regulation of serum magnesium homeostasis is not well understood.

21 We conducted a GWAS of serum magnesium in 2737 AA participants of the Atheroscl

22 i have been reported involving regulation of serum magnesium in adults.

23 ere to identify genetic loci associated with serum magnesium in an African-American (AA) population u

24 licated in a dataset from a previous GWAS of serum magnesium in European adults.

25 Low serum magnesium is moderately associated with the develo

26 highest frequency rate (72%) and lowest mean serum magnesium level (0.66 +/- 0.17 mmol/L) in patients

27 wed an inverse relationship between baseline serum magnesium level and NODAT (hazard ratio [HR], 1.24

28 31, 2011, to examine the association between serum magnesium level and NODAT.

29 r results suggest that lower post-transplant serum magnesium level is an independent risk factor for

30 te to severe shivering (p = 0.04), and lower serum magnesium levels (p = 0.01) were associated with g

31 f rs17251221 was also associated with higher serum magnesium levels (P = 1.2 * 10(-3)), lower serum p

32 Previous genetic studies indicate that serum magnesium levels are highly heritable, and a few g

33 Low serum magnesium levels could be associated with increase

34 Low serum magnesium levels have been associated with multipl

35 dy, we examined if additional loci influence serum magnesium levels in children.

36 iosis and craniofacial anomalies should have serum magnesium levels monitored closely after surgery.

37 ate ratios of ischemic stroke for those with serum magnesium levels of <or=1.5, 1.6, 1.7, and >or=1.8

38 Future studies are needed to test whether serum magnesium levels predict risk of HF.

39 Higher serum magnesium levels were associated with lower preval

40 Furthermore, in PRL-2 knockout mice, serum magnesium levels were significantly elevated as co

41 an for 3 months moving at 3-month intervals) serum magnesium levels while adjusting for potential con

42 and apparent recessive effects of C1QTNF8 on serum magnesium levels.

43 Hypomagnesemia (serum magnesium <0.74 mmol/L) also significantly associa

44 Hypomagnesemia (defined as total serum magnesium <0.75 mmol/L) was found in 51 (11%) of t

45 nterval, 6.7-11.9) in the lowest quartile of serum magnesium (</=1.77 mg/dL) compared with 6.3 per 10

46 Low serum magnesium (Mg) levels are associated with an incre

47 4142110 was correlated with higher levels of serum magnesium, phosphorus, and lower AKP level.

48 Magnesium doses were targeted to achieve serum magnesium ranges of 1.0-1.85 mmol/L or 1.25-2.5 mm

49 Restoring the concentrations of serum magnesium to normal values by high-dose magnesium

50 Interventions targeting serum magnesium to reduce the risk of NODAT should be ev

51 correlate with hypomagnesemia and to predict serum magnesium values in critically ill pediatric patie

52 Total serum magnesium values were obtained within the first 24

53 Mean serum magnesium was 1.88 mg/dL.

54 However, serum magnesium was in the upper normal to hypermagnesem

55 Serum magnesium was inversely associated with ischemic s

56 Serum magnesium was significantly negatively associated

57 odels, individuals in the lowest quartile of serum magnesium were ~50% more likely to develop AF (adj